Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Judge 

UnitedHealth Group Inc. diskutieren

UnitedHealth Group Inc.

WKN: 869561 / Symbol: UNH / Name: UnitedHealth / Aktie / Anbieter & Dienstleistungen / Large Cap /

460,55 €
0,32 %

Buy UnitedHealth Group Inc.

Buy UnitedHealth Group Inc.

Buy UnitedHealth Group Inc.

Sell UnitedHealth Group Inc.

Buy UnitedHealth Group Inc.

Buy UnitedHealth Group Inc.

Einschätzung Buy
Rendite (%) 1,53 %
Kursziel 569,31
Veränderung
Endet am 28.02.24

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $605.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

UnitedHealth Group Incorporated (NYSE: UNH) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for UNH provided by MarketBeat

UnitedHealth Group Incorporated (NYSE: UNH) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,12 %
Kursziel 577,08
Veränderung
Endet am 17.04.24

UnitedHealth Group Incorporated (NYSE: UNH) had its "strong-buy" rating re-affirmed by analysts at Raymond James. They now have a $630.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,12 %
Kursziel 542,27
Veränderung
Endet am 17.04.24

UnitedHealth Group Incorporated (NYSE: UNH) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $592.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

UnitedHealth Group Incorporated (NYSE: UNH) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 8,48 %
Kursziel 522,61
Veränderung
Endet am 14.07.24

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $587.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 8,10 %
Kursziel 494,28
Veränderung
Endet am 17.07.24

UnitedHealth Group Incorporated (NYSE: UNH) had its price target lowered by analysts at TD Cowen from $562.00 to $555.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 8,10 %
Kursziel 473,80
Veränderung
Endet am 17.07.24

UnitedHealth Group Incorporated (NYSE: UNH) had its price target raised by analysts at JPMorgan Chase & Co. from $527.00 to $532.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -0,16 %
Kursziel 510,83
Veränderung
Endet am 11.08.24

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $560.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,76 %
Kursziel 554,59
Veränderung
Endet am 14.09.24

UnitedHealth Group Incorporated (NYSE: UNH) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -10,64 %
Kursziel 606,91
Veränderung
Endet am 16.10.24

UnitedHealth Group Incorporated (NYSE: UNH) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $640.00 price target on the stock, up previously from $520.00.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,94 %
Kursziel 553,11
Veränderung
Endet am 16.10.24

UnitedHealth Group Incorporated (NYSE: UNH) had its price target raised by analysts at Piper Sandler from $580.00 to $584.00. They now have an "overweight" rating on the stock.
Ratings data for UNH provided by MarketBeat

Einschätzung Buy
Rendite (%) -9,41 %
Kursziel 564,11
Veränderung
Endet am 16.10.24

UnitedHealth Group Incorporated (NYSE: UNH) had its price target raised by analysts at Royal Bank of Canada from $572.00 to $596.00. They now have an "outperform" rating on the stock.
Ratings data for UNH provided by MarketBeat